March / April 2021
Features
Ocular gene therapy: The next generation
Emerging viral and synthetic vectors along with newer delivery platforms are poised to broaden genetic treatments in retina.
How COVID-19 has altered uveitis management
The pandemic has potentially changed the risk-benefit balance between local therapy and systemic immunosuppression.
AI in retina: Ready for prime time?
Artificial intelligence is ready to be incorporated into retina referral networks. Here’s a look at the state of the science.
Five evidence-based answers for PVD, retinal breaks
Answers to commonly encountered clinical questions about the clinical course of posterior vitreous detachment and symptomatic retinal breaks.
Departments
Clinical Trial Closeup
Targeted approach to pan-VEGF inhibition
A suprachoroidal formulation of axitinib, approved for renal cell carcinoma, may have potential for treating neovascular AMD.
Coding Commentary
New E/M codes are here. Now what?
A strategy for meeting the new requirements for Evaluation and Management codes.
Editor's Page
News
North of the Border
Six frugal faves for retinal surgery
A sample of simple, safe and cost-saving ideas for common procedures and imaging techniques with accompanying videos.
Retina Rounds
A curious case of RAMA
An incidental exam finding upends a 70-year-old woman’s back pain management plan.
Social Media Specialist
Confronting the cyberbully
Some guidance for retina specialists and physicians when they’re attacked on social media.
Surgical Pearl Video
A low-cost, one-person depressor
A technique for performing illuminated scleral depression for peripheral vitrectomy without an assistant.
Current Issue
Additional Publications
Learn More about Stargardt Disease
Earlier Treatment Can Matter for Macular Edema Following Retinal Vein Occlusion
Treating Chronic Inflammation Associated With Uveitis Affecting the Posterior Segment in a Retina Setting with YUTIQ
GA: Recognizing the Burden
Treatment of Proliferative Diabetic Retinopathy
